Givaudan SA Stock (CH0010645932): Deutsche Bank lifts rating to Buy and raises CHF 3,300 target

Givaudan shares are in focus after Deutsche Bank Research upgraded the stock to Buy and lifted its price target to CHF 3,300, while the Swiss fragrance maker trades largely sideways on the SIX Swiss Exchange.

Responsible: ad hoc news Stocks & Analysis Desk. Reviewed prior to publication on June 16, 2026 at 9:14 PM ET. Details in the imprint.

Givaudan SA is drawing attention on Tuesday after Deutsche Bank Research raised its rating on the Swiss fragrance and flavors specialist to "Buy" and increased its price target to CHF 3,300 per share. Around midday, however, the stock itself was trading only marginally changed on the SIX Swiss Exchange at about CHF 3,196, leaving the move more visible in the analyst community than in the day’s price chart so far. According to intraday data from finanzen.ch, the share briefly traded at CHF 3,202 in the morning session, up 0.1 percent, modestly supporting the SMI benchmark index.

Deutsche Bank upgrade puts Givaudan back on analysts' radar

According to a summary carried by ad hoc news, Deutsche Bank Research has shifted its view on Givaudan from a more cautious stance to a positive "Buy" recommendation and simultaneously lifted its price target to CHF 3,300 per share. The new target implies limited upside versus where the stock has been trading around CHF 3,196 to CHF 3,202 during Tuesday’s session on the SIX, but it still underlines renewed confidence in the company’s earnings power and strategic positioning. While the detailed Deutsche Bank report is not fully quoted in secondary coverage, the higher target normally reflects expectations for improving margins, resilient demand in core fragrance and taste markets, or execution on cost and innovation initiatives.

Givaudan is a leading global supplier of flavors, fragrances and active cosmetic ingredients, making it a key partner for consumer goods producers in segments such as perfumes, personal care, household products, beverages and packaged foods. This positioning gives the company broad exposure to consumer spending trends, raw material costs and the pricing power of branded product manufacturers, which are typical focal points for equity analysts. Rating changes by large banks like Deutsche Bank can therefore influence how portfolio managers perceive the balance between Givaudan’s defensive characteristics and its valuation multiples.

Recent commentary from European investor publications points out that the Givaudan share price is still trading significantly below earlier highs despite a recovery phase. One analysis notes that the stock is roughly 20 percent under a previous 52-week high, while the low from March is more than 20 percent behind the current level, underlining both prior volatility and a partial rebound. Another report highlights that, despite signs of recovery, the share price remains around 30 percent below peak levels, suggesting that sentiment, interest rates and sector rotation have weighed on premium-valued consumer staples suppliers in recent quarters. Against this backdrop, Deutsche Bank’s upgrade can be read as a signal that at least one major house now sees the current price as offering a more attractive risk-reward profile than earlier in the cycle.

Market data from finanzen.ch show that Givaudan’s stock hardly moved at 12:28 p.m. local time on Tuesday, trading at CHF 3,196, placing it among the more neutral performers in the SMI at that moment. Earlier in the morning session, at 9:28 a.m., the share had ticked up to CHF 3,202, a rise of 0.1 percent compared with the previous close, while the SMI itself stood at around 13,717 points. Around midday, the broader Swiss index continued to show a positive tone with a gain of about 0.51 percent at 13,787.64 points, underlining that the local market environment was supportive even as Givaudan’s individual move remained subdued. This pattern suggests that the Deutsche Bank rating change did not immediately translate into sharp trading activity, but it may affect positioning over a longer horizon as institutional investors incorporate the revised view.

From a fundamental standpoint, the debate around Givaudan often centers on the trade-off between its premium valuation and the stability of its cash flows. The company operates in a consolidated industry with high switching costs, as consumer brands tend to maintain long-term relationships with fragrance and flavor suppliers to ensure consistency in product taste and scent. Such characteristics typically support high margins and recurring revenue streams, which can justify higher earnings multiples relative to the broader market in the eyes of many analysts. However, when interest rates rise or growth expectations moderate, investors frequently rotate out of high-multiple defensive names, compressing valuations even if underlying earnings remain resilient.

In that light, Deutsche Bank’s move to a "Buy" rating signals a view that Givaudan’s current share price, after a period of underperformance versus historic highs, may no longer fully reflect the company’s earnings resilience and strategic assets. The bank’s CHF 3,300 price target is not dramatically above the current trading range, but it does sit above the roughly CHF 3,200 level seen on Tuesday, indicating scope for modest upside if the company can deliver against expectations. Analysts will closely watch upcoming quarterly updates for trends in volume growth, pricing, input costs and any commentary on demand from key categories such as fine fragrances, personal care and packaged foods.

European financial media also highlight that Givaudan has been active on the portfolio and acquisition side, which can be an additional factor in analyst assessments. Coverage referencing a "dufte" (fragrance-related) acquisition describes the company as pursuing bolt-on deals to strengthen its position in attractive niches, although the specific deal values and targets cited in some reports (including figures around EUR 185 million for Eurofragance) may reflect earlier transactions or strategic considerations not directly tied to today’s price move. Still, these activities underscore management’s willingness to reinvest cash flows into portfolio expansion, technology and capabilities, which large banks often factor into long-term earnings models and target prices.

While today’s trading in Zurich has been fairly calm, with intraday moves around 0.1 percent and prices clustered near CHF 3,200, the combination of a major rating upgrade and a still-depressed level versus past highs provides fresh context for how the market is viewing Givaudan. For investors following European consumer and ingredients stocks, the Deutsche Bank call adds another data point to a broader sector discussion that includes interest-rate sensitivity, the sustainability of premium brand spending and the evolution of input costs in chemicals and natural ingredients. Overall, Givaudan’s stock remains closely watched as a bellwether for both the fragrance and flavor industry and for high-quality, cash-generative European staples names more generally.

For now, the key near-term reference points are Deutsche Bank’s new CHF 3,300 target, the current trading range just below that level on the SIX Swiss Exchange, and the company’s upcoming investor communications, which will be scrutinized for confirmation of the more constructive analyst stance. Investors watching the stock may wish to compare Givaudan’s performance and valuation with peers in the flavors, fragrances and specialty ingredients segment as they assess how far the recent underperformance versus historical highs has reset expectations.

Key facts on the Givaudan stock

• Name: Givaudan SA
• Industry: Flavors, fragrances and cosmetic ingredients
• Headquarters: Vernier, Switzerland
• Core markets: Consumer fragrances, personal care, household products, beverages, packaged foods
• Revenue drivers: Long-term supply agreements for flavors and fragrances with global consumer goods companies; innovation in taste and scent solutions; expansion in emerging markets and cosmetic ingredients
• Listing: SIX Swiss Exchange, ticker GIVN (no primary US listing; accessible to US investors via international brokers)
• Trading currency: Swiss franc (CHF)

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.